Skip to main content
editorial
. 2014 Jan;145(1):17–20. doi: 10.1378/chest.13-2356

Table 3.

—Clinical Outcomes in the Second Multicenter Intrapleural Sepsis Trial

Outcome Tissue Plasminogen Activator Placebo P Value
Change in pleural opacification, % − 17.2 ± 24.3 − 17.2 ± 19.6 NS
Death (3 mo) 4 of 48 (8%) 6 of 46 (13%) NS
Surgical intervention (3 mo) 3 of 48 (6%) 6 of 51 (12%) .025
Hospital stay, d 16.5 ± 22.8 24.8 ± 56.1 .21
Serious adverse events 0 of 52 (0%) 1 of 55 (2%) NS

Data are presented as mean ± SD unless otherwise indicated. NS = not significant.